Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|16|2|120-162

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.16, Iss.2, 2016-01, pp. : 120-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldose reductase inhibitors: therapeutic implications for diabetic complications

By Oates P.J.   Mylari B.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2095-2119

Informa Healthcare

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Genetic Analysis of Aldose Reductase in Diabetic Complications

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1375-1387

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite